Factor | Univariate analysis | |
---|---|---|
Median survival (months) | P value | |
Gender | 0.365 | |
Male | 16.7 | |
Female | 18.4 | |
Age (years) | 0.459 | |
≤ 65 | 18.4 | |
> 65 | 16.7 | |
Tumor location | 0.540 | |
Gallbladder cancer | 17.1 | |
Cholangiocarcinoma | 18.4 | |
Pathological type | 0.009 | |
Adenocarcinoma | 9.7 | |
Squamous cell carcinoma | 18.4 | |
Tumor differentiation | 0.169 | |
Poor | 14.5 | |
Moderate | 24.3 | |
Well | 18.4 | |
Surgical margin | 0.664 | |
R0 | 17.1 | |
R + | 18.4 | |
Nerve invasion | 0.134 | |
Absent | 16.8 | |
Present | 24.1 | |
Vascular tumor thrombus | 0.027 | |
Absent | 24.1 | |
Present | 13.8 | |
Lymph node metastasis | 0.185 | |
N0 | 24.1 | |
N + | 17.1 | |
T category | 0.362 | |
T2 | 10.5 | |
T3 or T4 | 18.3 | |
AJCC stage (8th edition) | 0.034 | |
II | 26.4 | |
III | 16.8 | |
Treatment modality | 0.012 | |
No radiotherapy | 14.5 | |
Adjuvant radiotherapy | 28.9 |